Stockscreener 앱 받기
8.895
6.27%
0.525
Xeris Biopharma Holdings Inc 주식(XERS)의 최신 뉴스
Enterprise value to EBITDA forward of Xeris Biopharma Holdings, Inc. – NASDAQ:XERS - TradingView
Insider reports 400-share purchase and 17,000 RSUs | XERS SEC FilingForm 144 - Stock Titan
Xeris Biopharma Holdings, Inc. (XERS) Leads with High RSI of 84 - GuruFocus
Xeris Biopharma Holdings (XERS) Patent Win Puts Its Valuation Back In Focus - Sahm
CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Yahoo Finance
XERSXeris Biopharma Holdings Inc Options - Finviz
Beth Hecht Sells 16,666 Shares of Xeris Biopharma Holdings Inc (XERS) - GuruFocus
Form 4 Xeris Pharmaceuticals Inc For: 2 July By Investing.com - Investing.com India
Director at Xeris Biopharma (NASDAQ: XERS) receives stock and options grants - Stock Titan
Xeris Biopharma (XERS) director Nerissa Kreher listed as reporting person on Form 3 - Stock Titan
Xeris Biopharma (XERS) officer sells 90,000 shares under 10b5-1 plan - Stock Titan
Planned sale: Xeris Biopharma (XERS) officer trades 16,666 shares - Stock Titan
Insider 10b5-1 sales scheduled at XERS: 16,667 shares on 05/01 and 06/01/2026 - Stock Titan
[144] Xeris Biopharma Holdings, Inc. SEC Filing - Stock Titan
Xeris Pharmaceuticals appoints new director and board chair - TipRanks
Xeris Biopharma (NASDAQ: XERS) adds Nerissa Kreher and reshapes board - Stock Titan
Xeris CEO picks up chairman role at fast-growing biopharma - Crain's Chicago Business
Xeris Biopharma Holdings, Inc. Announces Board Changes, Effective July 1, 2026 - marketscreener.com
Is Xeris Biopharma Holdings, Inc. (XERS) Stock Positioned for Long-Term Growth With Extended Keveyis Exclusivity? - Insider Monkey
Xeris names CEO John Shannon as board chair, adds director By Investing.com - Investing.com Nigeria
Xeris names CEO John Shannon as board chair, adds director - Investing.com
Xeris Announces Updates to Its Board of Directors - Business Wire
5 Best Low-Priced Pharma Stocks to Buy Right Now - Insider Monkey
Xeris Biopharma Holdings, Inc. Actuals & Estimates (NASDAQ:XERS) - TradingView
Xeris Biopharma Holdings Inc (XERS) Institutional Confidence - TradingKey
XERS Forecast — Price Target — Prediction for 2027 - TradingView
0A8E Forecast — Price Target — Prediction for 2027 - TradingView
Xeris Biopharma (XERS) Short Interest & Short Float | Updated Jun 2026 $XERS - MarketBeat
Xeris Biopharma Holdings Inc (XERS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Xeris Biopharma Holdings Inc (XERS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
XERS News | XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) - ChartMill
Xeris Biopharma Holdings Inc (XERS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Xeris Biopharma Stocklong-term strategy under the microscope - AD HOC NEWS
Xeris Biopharma Holdings Inc (XERS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Xeris Biopharma Holdings Inc (XERS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Xeris Biopharma Holdings Inc - TradingKey
Xeris Biopharma Holdings Inc (XERS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Xeris Biopharma Holdings Inc (XERS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Xeris Biopharma Holdings Inc. (XERS) Q1 2026 Earnings: Surprise EPS Profitability Achieved Amid Mixed Market ReceptionDownward Estimate Revision - newsline.com
Jim Cramer Blesses a Caller’s Speculative Investment in Xeris Biopharma - Insider Monkey
Xeris Pharmaceuticals, Inc. (XERS) stock price, news, quote and history - Yahoo Finance UK
Xeris Biopharma Stock (US98422E1038): Debt Exchange Targets $23 Million Of 8% Convertible Notes - AD HOC NEWS
XERS Receives Notice of Allowance for Patent on Keveyis - GuruFocus
Xeris Biopharma Holdings, Inc. (XERS) Latest Stock News & Headlines - Yahoo Finance
XERS Enters Exchange Agreements to Retire Convertible Notes - GuruFocus
Xeris receives patent allowance for Keveyis through 2039 By Investing.com - Investing.com Canada
Xeris Biopharma Announces Notice of Allowance From U.S. Patent and Trademark Office for New Patent Covering KEVEYIS - Business Wire
Xeris Biopharma Announces Debt Exchange Agreement to Strengthen Balance Sheet - GuruFocus
Jim Cramer Discussed 15 Stocks, Including Broadcom, Netflix, and His Skepticism Toward Tech Stocks - Insider Monkey
XERS Q1 2026 Earnings: EPS Surprise of 217.65% Drives Stock HigherPre-Announcement Alert - newsline.com
Xeris to retire $23M of convertible notes through exchange agreements - MSN
Xeris Biopharma to Retire $23 Million of Convertible Notes Through Private Exchange - marketscreener.com
Xeris Biopharma Announces Private Exchange of Convertible Notes - BioSpace
Xeris Biopharma to retire $23 million in convertible notes By Investing.com - Investing.com Australia
Xeris Biopharma (XERS) Retires $23M in Convertible Notes Through Exchange - GuruFocus
0.17%
1.83%
자본화:
|
볼륨(24시간):